Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on (S) 4 Chloro 3 hydroxybutyrate Ethyl Ester. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN106754775B details ScCR1 mutants for Atorvastatin intermediate. Offers high stability and activity for cost-effective manufacturing.
Patent CN101392225B details a recombinant yeast method for high-purity statin intermediates, offering significant cost reduction in API manufacturing and supply chain reliability.